Prevention and Management of Non-Infectious Co-Morbidities in HIV

Index - 28 - 29 - 30/31 - 32/33/34 - 35 - 36/37/38/39 - 40/41 - 42/43 - 44/45/46 - 47/48 - 49 - 50/51/52/53
54/55 - 56 - 57/58 - 59 - 60/61 - 62 - Pages online: A - B - C - D - E - F - G - References

CLASSIFICATION, DOSES, SAFETY AND SIDE EFFECTS OF ANTIDEPRESSANTS

Mechanisms of action and classification	Starting dose	Standard dose	Lethality in overdose	Insomnia and agitation	Sedation	Nausea or gastro-intestinal effects	Sexual dysfunction	Weight gain
Mechanisms of action and classification	mg/day		Lethality in overdose	Insomnia and agitation	Sedation	Nausea or gastro-intestinal effects	Sexual dysfunction	Weight gain
Selective serotonin-reuptake inhibitors (SSRIs)
Paroxetine (Paxil)	20	20-40	low	+	- or +	+	+	+
Sertraline (Zoloft)	50	50-150	low	+	- or +	+	+	+
Citalopram (Celexa)	20	20-40	low	+	- or +	+	+	+
Mixed or dual-action reuptake inhibitors
Venlafaxine (Efexor)	37-75	75-225	moderate	+	- or +	+	+	- or +
Mixed-action newer agents
Mirtazapine (Remeron) (5-HT₂ plus 5-HT₃ plus α₂-adrenergic receptors)	30	30-60	low	- or +	++	- or +	- or +	++

= none;

= moderate;

= severe